Dr. Andrea Eberle

  • 1985-1992 Study of Biology at the University of Bremen, Degree: Diploma
  • 1992-1996 Scientist at the University of Bremen
  • 1996-1998 Study of Public Health at the University of Bremen, Degree: MPH
  • Since 1998 Scientist at the Leibniz Institute for Prevention Research and Epidemiology, Cancer Registry.

cancer epidemiology

    Selected BIPS-Publications

  • Articles with peer review

  • Jansen L, Schwettmann L, Behr C, Eberle A, Holleczek B, Justenhoven C, Kajüter H, Manz K, Peters F, Pritzkuleit R, Schmidt-Pokrzywniak A, Sirri E, Tetzlaff F, Voigtländer S, Arndt V. Trends in cancer incidence by socioeconomic deprivation in Germany in 2007 to 2018: An ecological registry-based study. International Journal of Cancer. 2023;153(10):1784-1796.
    https://doi.org/10.1002/ijc.34662
  • Katalinic A, Halber M, Meyer M, Pflüger M, Eberle A, Nennecke A, Kim-Wanner S-Z, Hartz T, Weitmann K, Stang A, Justenhoven C, Holleczek B, Piontek D, Wittenberg I, Heßmer A, Kraywinkel K, Spix C, Pritzkuleit R. Population-based clinical cancer registration in Germany. Cancers. 2023;15(15):3934.
    https://doi.org/10.3390/cancers15153934
  • Liu Z, Thong MS-Y, Doege D, Koch-Gallenkamp L, Weißer L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Pritzkuleit R, Brenner H, Arndt V. Benefit finding, posttraumatic growth and health-related quality of life in long-term cancer survivors: A prospective population-based study. Acta Oncologica. 2023;62(9):1124-1131.
    https://doi.org/10.1080/0284186X.2023.2245560
  • Thong MS-Y, Doege D, Weißer L, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Brenner H, Arndt V. Persisting deficits in health-related quality of life of colorectal cancer survivors 14-24 years post-diagnosis: A population-based study. Current Oncology. 2023;30(3):3373-3390.
    https://doi.org/10.3390/curroncol30030257
  • Doege D, Thong MS-Y, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Nennecke A, Pritzkuleit R, Waldmann A, Zeissig SR, Brenner H, Arndt V. Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors. Journal of Cancer Research and Clinical Oncology. 2022;148(12):3461-3473.
    http://doi.org/10.1007/s00432-022-04204-w
  • Kollhorst B, Reinders T, Grill S, Eberle A, Intemann T, Kieschke J, Meyer M, Nennecke A, Rathmann W, Pigeot I. Record linkage of claims and cancer registries data - Evaluation of a deterministic linkage approach based on indirect personal identifiers. Pharmacoepidemiology and Drug Safety. 2022;31(12):1287-1293.
    https://doi.org/10.1002/pds.5545
  • Pigeot I, Bongaerts B, Eberle A, Katalinic A, Kieschke J, Luttmann S, Meyer M, Nennecke A, Rathmann W, Stabenow R, Wilsdorf-Köhler H, Kollhorst B, Reinders T. Verknüpfung von Abrechnungsdaten gesetzlicher Krankenkassen mit Daten epidemiologischer Krebsregister: Länderspezifische Möglichkeiten und Limitationen. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2022;65(5):615-623.
    https://doi.org/10.1007/s00103-021-03475-x
  • Thong MS-Y, Doege D, Weißer L, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Pritzkuleit R, Schlander M, Brenner H, Arndt V. Health and life insurance-related problems in very long-term cancer survivors in Germany: A population-based study. Journal of Cancer Research and Clinical Oncology. 2022;148(1):155-162.
    https://doi.org/10.1007/s00432-021-03825-x
  • Doege D, Thong MS-Y, Weißer L, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Nennecke A, Pritzkuleit R, Waldmann A, Zeissig SR, Brenner H, Arndt V. Health-related quality of life in very long-term cancer survivors 14-24 years post-diagnosis compared to population controls: A population-based study. Cancers. 2021;13(11):2754.
    https://doi.org/10.3390/cancers13112754
  • Liu Z, Doege D, Thong MS-Y, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Pritzkuleit R, Arndt V. Distress mediates the relationship between cognitive appraisal of medical care and benefit finding/posttraumatic growth in long-term cancer survivors. Cancer. 2021;127(19):3680-3690.
    https://doi.org/10.1002/cncr.33684
  • Liu Z, Thong MS-Y, Doege D, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Waldmann A, Zeissig SR, Pritzkuleit R, Brenner H, Arndt V. Prevalence of benefit finding and posttraumatic growth in long-term cancer survivors: Results from a multi-regional population-based survey in Germany. British Journal of Cancer. 2021;125(6):877-883.
    https://doi.org/10.1038/s41416-021-01473-z
  • Adam S, Doege D, Koch-Gallenkamp L, Thong MS-Y, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Jansen L, Rohrmann S, Brenner H, Arndt V. Age-specific health-related quality of life in disease-free long-term prostate cancer survivors versus male population controls - Results from a population-based study. Supportive Care in Cancer. 2020;28(6):2875-2885.
    https://doi.org/10.1007/s00520-019-05120-5
  • Brunssen A, Jansen L, Eisemann N, Waldmann A, Weberpals J, Kraywinkel K, Eberle A, Holleczek B, Zeissig SR, Brenner H, Katalinic A, GEKID Cancer Survival Working Group. Long-term relative survival from melanoma in Germany 1997-2013. Melanoma Research. 2020;30(4):386-395.
    https://doi.org/10.1097/CMR.0000000000000482
  • Doege D, Thong MS-Y, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldmann A, Zeissig SR, Brenner H, Arndt V. Age-specific prevalence and determinants of depression in long-term breast cancer survivors compared to female population controls. Cancer Medicine. 2020;9(22):8713-8721.
    https://doi.org/10.1002/cam4.3476
  • Jansen L, Holleczek B, Kraywinkel K, Weberpals J, Schröder CC, Eberle A, Emrich K, Kajüter H, Katalinic A, Kieschke J, Nennecke A, Sirri E, Heil J, Schneeweiss A, Brenner H, on behalf of the GEKID Cancer Survival Working Group. Divergent patterns and trends in breast cancer incidence, mortality and survival among older women in Germany and the United States. Cancers. 2020;12(9):2419.
    https://doi.org/10.3390/cancers12092419
  • Sirri E, Kieschke J, Vohmann C, Katalinic A, Nennecke A, Ressing M, Eberle A, Holleczek B, Jansen L, Brenner H, on behalf of the GEKID Cancer Survival Working Group. Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study. International Journal of Cancer. 2020;147(6):1548-1558.
    https://doi.org/10.1002/ijc.32931
  • Adam S, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Rohrmann S, Brenner H, Arndt V. Health-related quality of life in long-term survivors with localised prostate cancer by therapy - Results from a population-based study. European Journal of Cancer Care. 2019;28(5):e13076.
    https://doi.org/10.1111/ecc.13076
  • Arndt V, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Doege D, Thong MS-Y, Brenner H. Return to work after cancer: A multi-regional population-based study from Germany. Acta Oncologica. 2019;58(5):811-818.
    https://doi.org/10.1080/0284186X.2018.1557341
  • Brunssen A, Jansen L, Eisemann N, Waldmann A, Weberpals J, Kraywinkel K, Eberle A, Holleczek B, Zeissig SR, Brenner H, Katalinic A, on behalf of the GEKID Cancer Survival Working Group. A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype. Journal of the American Academy of Dermatology. 2019;80(4):938-946.
    https://doi.org/10.1016/j.jaad.2018.09.018
  • Doege D, Thong MS-Y, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Jansen L, Brenner H, Arndt V. Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany. Breast Cancer Research and Treatment. 2019;175(2):499-510.
    https://doi.org/10.1007/s10549-019-05188-x
  • Doege D, Thong MS-Y, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V. The role of psychosocial resources for long-term breast, colorectal, and prostate cancer survivors: Prevalence and associations with health-related quality of life. Supportive Care in Cancer. 2019;27(1):275-286.
    https://doi.org/10.1007/s00520-018-4317-8
  • Thong MS-Y, Doege D, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V. Age at diagnosis and sex are associated with long-term deficits in disease-specific health-related quality of life of survivors of colon and rectal cancer: A population-based study. Diseases of the Colon and Rectum. 2019;62(11):1294-1304.
    https://doi.org/10.1097/DCR.0000000000001489
  • Thong MS-Y, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V. Age-specific health-related quality of life in long-term and very long-term colorectal cancer survivors versus population controls - A population-based study. Acta Oncologica. 2019;58(5):801-810.
    https://doi.org/10.1080/0284186X.2018.1557340
  • Ressing M, Wardelmann E, Hohenberger P, Jakob J, Kasper B, Emrich K, Eberle A, Blettner M, Zeissig SR. Strengthening health data on a rare and heterogeneous disease: Sarcoma incidence and histological subtypes in Germany. BMC Public Health. 2018;18:235.
    https://doi.org/10.1186/s12889-018-5131-4
  • Thong MS-Y, Wolschon E-M, Koch-Gallenkamp L, Waldmann A, Waldeyer-Sauerland M, Pritzkuleit R, Bertram H, Kajüter H, Eberle A, Holleczek B, Zeissig SR, Brenner H, Arndt V. "Still a cancer patient" - Associations of cancer identity with patient-reported outcomes and health care use among cancer survivors. JNCI Cancer Spectrum. 2018;2(2):pky031.
    https://doi.org//10.1093/jncics/pky031
  • Arndt V, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H. Quality of life in long-term and very long-term cancer survivors versus population controls in Germany. Acta Oncologica. 2017;56(2):190-197.
    https://doi.org/10.1080/0284186X.2016.1266089
  • Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V. Progredienzangst >= 5 Jahre nach Krebsdiagnose - Ergebnisse der krebsregisterbasierten, bevölkerungsbasierten CAESAR-Studie. Der Onkologe. 2017;23(4):295-299.
    https://doi.org/10.1007/s00761-017-0188-8
  • Brenner H, Castro FA, Eberle A, Emrich K, Holleczek B, Katalinic A, Jansen L, for the GEKID Cancer Survival Workgroup. Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time. European Journal of Cancer. 2016;52(1):102-108.
    https://doi.org/10.1016/j.ejca.2015.10.059
  • Chen T, Fallah M, Brenner H, Jansen L, Mai EK, Castro FA, Krilaviciute A, Katalinic A, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist K, Hemminki K, for the GEKID Cancer Survival Workgroup. Risk of second primary cancers in multiple myeloma survivors in German and Swedish cancer registries. Scientific Reports. 2016;6:22084.
    https://doi.org/10.1038/srep22084
  • Eisemann N, Jansen L, Castro FA, Chen T, Eberle A, Nennecke A, Zeissig SR, Brenner H, Katalinic A, for the GEKID Cancer Survival Workgroup. Survival with nonmelanoma skin cancer in Germany. The British Journal of Dermatology. 2016;174(4):778-785.
    https://doi.org/10.1111/bjd.14352
  • Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V. Fear of recurrence in long-term cancer survivors - Do cancer-type, sex, time since diagnosis, and social support matter? Health Psychology. 2016;35(12):1329-1333.
    https://doi.org/10.1037/hea0000374
  • Chen T, Fallah M, Jansen L, Castro FA, Krilaviciute A, Katalinic A, Eisemann N, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist J, Brenner H, Hemminki K, GEKID Cancer Survival Working Group. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries. Cancer Letters. 2015;369(1):152-166.
    https://doi.org/10.1016/j.canlet.2015.08.014
  • Eberle A, Jansen L, Castro FA, Krilaviciute A, Luttmann S, Emrich K, Holleczek B, Nennecke A, Katalinic A, Brenner H, GEKID Survival Working Group. Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients. Lung Cancer. 2015;90(3):528-533.
    https://doi.org/10.1016/j.lungcan.2015.10.007
  • Francisci S, Minicozzi P, Pierannunzio D, Ardanaz E, Eberle A, Grimsrud TK, Knijn A, Pastorino U, Salmerón D, Trama A, Sant M, on behalf of the EUROCARE-5 Working Group. Survival patterns in lung and pleural cancer in Europe: Results from the EUROCARE-5 study. European Journal of Cancer. 2015;51(15):2242-2253.
    https://doi.org/10.1016/j.ejca.2015.07.033
  • Jansen L, Castro FA, Gondos A, Krilaviciute A, Barnes B, Eberle A, Emrich K, Hentschel S, Holleczek B, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Recent cancer survival in Germany: An analysis of common and less common cancers. International Journal of Cancer. 2015;136(11):2649-2658.
    https://doi.org/10.1002/ijc.29316
  • Zeissig SR, Singer S, Koch L, Zeeb H, Merbach M, Bertram H, Eberle A, Schmid-Höpfner S, Holleczek B, Waldmann A, Arndt V. Utilisation of psychosocial and informational services in immigrant and non-immigrant German cancer survivors. Psycho-Oncology. 2015;24(8):919-925.
    https://doi.org/10.1002/pon.3742
  • Jansen L, Eberle A, Emrich K, Gondos A, Holleczek B, Kajüter H, Maier W, Nennecke A, Pritzkuleit R, Brenner H, GEKID Cancer Survival Working Group. Socio-economic deprivation and cancer survival in Germany: An ecological analysis in 200 districts in Germany. International Journal of Cancer. 2014;134(12):2951-2960.
    https://doi.org/10.1002/ijc.28624
  • Koch L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V. Fear of recurrence in long-term breast cancer survivors - still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the Cancer Survivorship - A multi-regional population-based study. Psycho-Oncology. 2014;23(5):547-554.
    https://doi.org/10.1002/pon.3452
  • Nennecke A, Geiss K, Hentschel S, Vettorazzi E, Jansen L, Eberle A, Holleczek B, Gondos A, Brenner H, GEKID Cancer Survival Working Group. Survival of cancer patients in urban and rural areas of Germany - A comparison. Cancer Epidemiology. 2014;38(3):259-265.
    https://doi.org/10.1016/j.canep.2014.02.011
  • Pulte D, Jansen L, Gondos A, Katalinic A, Barnes B, Ressing M, Holleczek B, Eberle A, Brenner H, GEKID Cancer Survival Working Group. Survival of adults with acute lymphoblastic leukemia in Germany and the United States. PLOS ONE. 2014;9(1):e85554.
    https://doi.org/10.1371/journal.pone.0085554
  • Gondos A, Hiripi E, Holleczek B, Luttmann S, Eberle A, Brenner H, GEKID Cancer Survival Working Group. Survival among adolescents and young adults with cancer in Germany and the United States: An international comparison. International Journal of Cancer. 2013;133(9):2207-2215.
    https://doi.org/10.1002/ijc.28231
  • Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, Nennecke A, Eberle A, Brenner H, GEKID Cancer Survival Working Group. Sex differences in colorectal cancer survival: Population-based analysis of 164,996 colorectal cancer patients in Germany. PLOS ONE. 2013;8(7):e68077.
    https://doi.org/10.1371/journal.pone.0068077
  • Nennecke A, Barnes B, Brenner H, Eberle A, Emrich K, Eisemann N, Geiss K, Hentschel S, Holleczek B, Kraywinkel K, Stabenow R, Hense H-W. Datenqualität oder Unterschiede in der onkologischen Versorgung? - Berichtsstandards für Überlebenszeitanalysen mit Krebsregisterdaten. Das Gesundheitswesen. 2013;75(2):94-98.
    https://doi.org/10.1055/s-0032-1311622
  • Stang A, Jansen L, Trabert B, Rusner C, Eberle A, Katalinic A, Emrich K, Holleczek B, Brenner H, GEKID Cancer Survival Working Group. Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: A high resolution study by histology and age. Cancer Epidemiology. 2013;37(4):492-497.
    https://doi.org/10.1016/j.canep.2013.03.017
  • Schnoor M, Waldmann A, Eberle A, Holleczek B, Katalinic A. Colorectal cancer incidence in Germany: Stage-shift 6 years after implementation of colonoscopy screening programme. Cancer Epidemiology. 2012;36(5):417-420.
    https://doi.org/10.1016/j.canep.2012.04.008
  • Eberle A, Luttmann S, Foraita R, Pohlabeln H. Socioeconomic inequalities in cancer incidence and mortality - spatial analysis in Bremen/Germany. Journal of Public Health. 2010;18(3):227-235.
    https://doi.org/10.1007/s10389-009-0306-1
  • Nennecke A, Brenner H, Eberle A, Geiss K, Holleczek B, Kieschke J, Kraywinkel K, GEKID-Arbeitsgruppe "Überlebenszeitanalyse". Überlebenschancen von Krebspatienten in Deutschland - auf dem Weg zu repräsentativen, vergleichbaren Aussagen. Das Gesundheitswesen. 2010;72(10):692-699.
    https://doi.org/10.1055/s-0029-1242772
  • Luoto R, Kharazmi E, Niemi R, Eberle A, Giersiepen K. Hypertension and pelvic inflammatory disease in women with leiomyomata - Evidence from Germany and Finland. The Internet Journal of Gynecology and Obstetrics. 2008;10(1)
  • Braun S, Behrens T, Kulp W, Eberle A, Greiner W, Ahrens W, Graf von der Schulenburg J-M. Neuraminidasehemmer in der Therapie und Postexpositionsprophylaxe der Influenza. GMS Health Technology Assessment. 2006;2:Doc02.
    http://www.egms.de/en/journals/hta/2006-2/hta000015.shtml
  • Lehnert M, Eberle A, Hentschel S, Katalinic A, Kieschke J, Schmidtmann I, Schubert-Fritschle G, Stegmaier C, Hense H-W. Das maligne Melanom der Haut in epidemiologischen Krebsregistern in Deutschland - Inzidenz, klinische Parameter, Variationen in der Erhebung. Das Gesundheitswesen. 2005;67(10):729-735.
    https://doi.org/10.1055/s-2005-858696
  • Articles without peer review

  • Luttmann S, Eberle A, Hübner J. Epidemiologie der Adenokarzinome des Ösophagus und des ösophagogastralen Übergangs. Die Onkologie. 2023;29(6):470-478.
    https://doi.org/10.1007/s00761-023-01350-9
  • Doege D, Thong MS-Y, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Nennecke A, Pritzkuleit R, Waldmann A, Zeissig SR, Brenner H, Arndt V. Depression und subjektive kognitive Beeinträchtigung bei Langzeit-Brustkrebsüberlebenden. Gynäkologische Praxis. 2021;48(1):22-30.
  • Stegmaier C, Brenner H, Eberle A, Giersiepen K, Hentschel S, Nennecke A. Drei Krebsregister werten aus: Ist die Krebsinzidenz ab 70 höher? FORUM der Deutschen Krebsgesellschaft. 2008;23(1):27-32.
  • Guidelines and reports

  • Eberle A, Luttmann S. Krebserkrankungen im Land Bremen 2008 - 2009 mit Daten zur Krebsprävalenz. Bremen 2012.
  • Luttmann S, Eberle A, Brünings-Kuppe C, Lehmann C, Reineke B. Jahresbericht des Bremer Krebsregisters. Bremen 2010.
  • Eberle A, Luttmann S, Brünings-Kuppe C, Lehmann C, Reineke B. Jahresbericht des Bremer Krebsregisters. Krebserkrankungen im Land Bremen 2000-2005. Bremen 2008.
  • Eberle A, Giersiepen K. Jahresbericht des Bremer Krebsregisters. Bremen 2007.
  • Books

  • Jahn I, Eberle A, Niehues C. in collaboration with Birn A, Horch K. Gebärmutter-Erkrankungen. Berlin: Eigenverlag; 2007.
  • Giersiepen K, Luoto R, Eberle A, editors. Hysterectomy prevalence and its effect on uterine cancer incidence registration. Proceedings of the Bremen Meeting on Women's Health, May 19, 2001. Berlin: Verlag für Wissenschaft und Forschung; 2003.
  • Book chapters

  • Eberle A. Kleinräumige Analyse zum Zusammenhang von sozio-ökonomischer Schicht und Krebsinzidenz und -mortalität in Bremen. In: Hornberg C, Pauli A, editors. Umweltgerechtigkeit - Die soziale Verteilung von gesundheitsrelevanten Umweltbelastungen. Bielefeld: Laurenti. 2009. S. 132-138.

For further publications please follow this link:

The responsibility for the content of this page lies with Andrea Eberle.

Contact

Phone:
+49 (0)421 218-56-962